CompletedPhase 1NCT00259805
A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
Studying Rasmussen subacute encephalitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- California Pacific Medical Center Research Institute
- Principal Investigator
- Kenneth D Laxer, M.D., M.DCalifornia Pacific Medical Center
- Intervention
- Rituximab(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 5-25 years · All sexes
- Timeline
- 2005 – 2008
Study locations (1)
- California Pacific Medical Center, San Francisco, California, United States
Collaborators
Genentech, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00259805 on ClinicalTrials.gov